Frequency and spectrum of atypical BCR-ABL1 transcripts in chronic myeloid leukemia
The BCR-ABL1 oncogene is the molecular hallmark of chronic myeloid leukemia (CML) with the majority of patients possessing a fusion between BCR exon 13 or 14 and ABL1 exon a2 (e13a2 and e14a2 respectively). However, a minority of patients express...
Saved in:
| Date: | 2023 |
|---|---|
| Main Authors: | Kearney, L., Crampe, M., Langabeer, S.E. |
| Format: | Article |
| Language: | English |
| Published: |
PH Akademperiodyka
2023
|
| Subjects: | |
| Online Access: | https://exp-oncology.com.ua/index.php/Exp/article/view/2020-1-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Journal Title: | Experimental Oncology |
Institution
Experimental OncologySimilar Items
-
Suboptimal molecular response to tyrosine kinase inhibition associated with acquisition of a T240A ABL1 kinase domain mutation in a patient with chronic myeloid leukemia
by: Langabeer, S.E., et al.
Published: (2023) -
Inhibition of USP1, a new partner of Bcr-Abl, results in decrease of Bcr-Abl level in K562 cells
by: Antonenko, S.V., et al.
Published: (2023) -
Role of the hybrid Bcr/Abl kinase in the pathogenesis of chronic myeloid leukemia lacking C-Abl and CXCR4 proteins
by: L. A. Polishchuk, et al.
Published: (2014) -
Role of the hybrid Bcr/Abl kinase in the pathogenesis of chronic myeloid leukemia lacking C-Abl and CXCR4 proteins
by: Polishchuk, L.A., et al.
Published: (2014) -
ЯДЕРНА ЛОКАЛІЗАЦІЯ BCR І КОРТАКТИНУ ВКАЗУЄ НА ЇХ ПОТЕНЦІЙНУ РОЛЬ В РЕГУЛЯЦІЇ РОЗГАЛУЖЕННЯ АКТИНУ В ЯДРІ
by: Gurianov, D.S., et al.
Published: (2023)